Czech urology, 2023 (vol. 27), issue 4

Editorial

Olga Dolejšová

Ces Urol 2023, 27(4):212  

Microwave ablation and its role in treatment of small renal tumors

Eva Korčáková, Hynek Mírka, Kristýna Štajdlová, Roman Bosman, Adriena Bartoš Veselá, Tomáš Pitra, Kristýna Pivovarčíková, Milan Hora

Ces Urol 2023, 27(4):213-221 | DOI: 10.48095/cccu2023027  

Korčáková E., Mírka H., Štajdlová K., Bosman R., Bartoš Veselá A., Pitra T., Pivovarčíková K., Hora M. Microwave ablation and its role in treatment of small renal tumors. Current diagnostic methods are capable of detection small kidney tumors, and many of them are found incidentally during imaging for a different indication. This increase the number of low-stage tumors opens the door to less invasive treatment techniques in situations, when active surveillance is not indicated. Microwave ablation (MWA) is one of thermal ablation methods, which is coming to the fore recently. Its advantage is minimal invasiveness, comfort for the patient and the interventional...

Endometriosis of the urinary tract

Michal Buchta, Oldřich Matys, Martin Němec

Ces Urol 2023, 27(4):222-235 | DOI: 10.48095/cccu2023028  

Buchta M., Matys O., Němec M. Endometriosis of the urinary tract. In this article, the authors approach the issue of endometriosis of the urinary tract as a diagnostic unit that a urologist may encounter in his practice. It is a form of deep infiltrating endometriosis and refers to the presence of ectopic endometrial tissue invading the bladder, ureter, kidney and urethra. Symptomatology is expressed in 50-70% of cases and includes cyclic hematuria, recurrent dysuria, pollakisuria, cystalgia or nephrolgia. Therapy management is watchful waiting, hormonal or surgical. The choice of the appropriate approach depends on the patient's preferences and on...

Holmium laser enucleation of the prostate (HoLEP)

Pavel Tolinger, Aleš Petřík

Ces Urol 2023, 27(4):236-242 | DOI: 10.48095/cccu2023030  

Tolinger P., Petřík A. Holmium laser enucleation of prostate (HoLEP). For nearly a century, methods limited by the size of the prostate have been established as the gold standard of surgery for benign prostatic hyperplasia (BPH). For glands over 80g open prostatectomy (OP) and for smaller ones transurethral prostatectomy (TURP). Despite their indisputable effect, they bring a high rate of morbidity. The technological development of the 90s of the 20th century enabled new surgical procedures of which Holmium laser enucleation of the prostate (HoLEP) is established as a size-independent method. We try to provide an overview of the development of the...

Consequences of comprehensive oncological treatment on male sexuality

Taťána Šrámková

Ces Urol 2023, 27(4):243-250 | DOI: 10.48095/cccu2023032

Šrámková T. Consequences of comprehensive oncological treatment on male sexuality. The prevalence and incidence of malignancies in the Czech Republic is increasing. Advances in the diagnosis and treatment modalities applied in the field of oncology during the last decade have led to an increase in the overall survival of patients with many different types of tumors. As a result, maintaining quality of life is another important issue for oncology patients. Sexual problems in oncology patients can stem from impairment of libido, arousal, orgasm and ejaculation, sexual satisfaction and pain. Prostate, bladder and colorectal cancer are the most common...

Long­‑term results of neoadjuvant chemotherapy and radical cystectomy in the treatment of muscle invasive bladder cancer

Roman Hrabec, Alexandr Poprach, Ivo Čapák, Michal Uher, Markéta Hulová, Natália Šebová, Radek Lakomý, Jan Doležel, Michal Staník

Ces Urol 2023, 27(4):251-261 | DOI: 10.48095/cccu2023031  

Hrabec R., Poprach A., Čapák I., Uher M., Hulová M., Šebová N., Lakomý R., Doležel J., Staník M. Long­‑term results of neoadjuvant chemotherapy and radical cystectomy in the treatment of muscle invasive bladder cancer. Aims: Neoadjuvant chemotherapy (NAC) with radical cystectomy (RC) is the recommended treatment for muscle invasive bladder tumors (MIBC). However, more than half of patients are unable to undergo NAC due to contraindications. The aim of the study is to evaluate the long­‑term oncological results from one tertiary center and thus demonstrate the effectiveness of neoadjuvant chemotherapy in muscle­‑invasive bladder tumors....

Report from the CUS JEP 2023 Annual Conference

Jiří Ladman

Ces Urol 2023, 27(4):262-266  

ERUS 2023 - the new robotic age

Vojtěch Novák

Ces Urol 2023, 27(4):267-268  

Czech Urology Boot Camp 2023

Tereza Zdobinská, Dalibor Jozef Fedák, Ondřej Příman, Vojtěch Novák

Ces Urol 2023, 27(4):269-271  

Prostate Cancer 2023 Interactive Workshop Report

Alžběta Kantorová

Ces Urol 2023, 27(4):272-273

Professor Jan Dvořáček, MD, DrSc., was awarded the Charles University Commemorative Medal on the anniversary of his birth

Kolektiv pracovníků

Ces Urol 2023, 27(4):274  

Results of the 2022 best scientific publication competition of the Czech urological society

Redakce

Ces Urol 2023, 27(4):275-278